Journal of Clinical Medicine · 2019 · 25 citations · 26 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceAntimicrobial Resistance EpidemiologyMusculoskeletal InfectionAntibiotic ResistanceBacterial EpidemiologyBacterial InfectionsBone InfectionsMicrobiology Of Musculoskeletal InfectionNosocomial InfectionsAntibiotic Resistance MarkersProsthetic Infection
Methicillin-resistant Staphylococcus aureus (MRSA) causes superficial infections such as cellulitis or invasive infections such as osteomyelitis; however, differences in MRSA isolates from cellulitis (CL-MRSA) and from osteomyelitis (OM-MRSA) at the same local area remain largely unknown. A total of 221 MRSA isolates including 106 CL-MRSA strains and 115 OM-MRSA strains were collected at Chang-Gung Memorial Hospital in Taiwan between 2016 and 2018, and their genotypic and phenotypic characteristics were compared. We found that OM-MRSA isolates significantly exhibited higher rates of resistance to multiple antibiotics than CL-MRSA isolates. Genotypically, OM-MRSA isolates had higher proportions of the SCCmec type III, the sequence type ST239, and the spa type t037 than CL-MRSA isolates. Besides the multidrug-resistant lineage ST239-t037-SCCmecIII more prevalent in OM-MRSA, higher antibiotic resistance rates were also observed in several other prevalent lineages in OM-MRSA as compared to the same lineages in CL-MRSA. Furthermore, when prosthetic joint infection (PJI) associated and non-PJI-associated MRSA strains in osteomyelitis were compared, no significant differences were observed in antibiotic resistance rates between the two groups, albeit more diverse genotypes were found in non-PJI-associated MRSA. Our findings therefore suggest that deep infections may allow MRSA to evade antibiotic attack and facilitate the convergent evolution and selection of multidrug-resistant lineages.
26
Mark C. Enright, Nicholas Day, Catrin E. Davies et al. · Journal of Clinical Microbiology · 2000 · 3K citations · Full text
François Vandenesch, Timothy S. Naimi, Mark C. Enright et al. · Emerging infectious diseases · 2003 · 1.7K citations · Full text
"Celbenin" - resistant Staphylococci
M. P. Jevons · BMJ · 1961 · 1.7K citations · Full text
Dag Harmsen, Heike Claus, Wolfgang Witte et al. · Journal of Clinical Microbiology · 2003 · 1.6K citations · Full text